Nurix Therapeutics Inc
(NRIX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
| 05-2022 | 02-2022 | 11-2021 | 08-2021 | 05-2021 | |
| Sales | 11,432 | 9,621 | 7,396 | 10,252 | 7,091 |
| Gross Profit | 11,432 | 9,621 | 7,396 | 10,252 | 7,091 |
| Operating Expenses | 57,147 | 52,365 | 45,349 | 39,249 | 33,505 |
| Operating Income | -45,715 | -42,744 | -37,953 | -28,997 | -26,414 |
| Other Income | 314 | 211 | 295 | 39 | 171 |
| Pre-tax Income | -45,401 | -42,533 | -37,658 | -28,958 | -26,243 |
| Income Tax | N/A | N/A | 44 | -123 | 139 |
| Net Income Continuous | -45,401 | -42,533 | -37,702 | -28,835 | -26,382 |
| Net Income | $-45,401 | $-42,533 | $-37,702 | $-28,835 | $-26,382 |
| EPS Basic Total Ops | -1.01 | -0.95 | -0.85 | -0.65 | -0.60 |
| EPS Basic Continuous Ops | -1.01 | -0.95 | -0.85 | -0.65 | -0.60 |
| EPS Diluted Total Ops | -1.01 | -0.95 | -0.85 | -0.65 | -0.60 |
| EPS Diluted Continuous Ops | -1.01 | -0.95 | -0.85 | -0.65 | -0.60 |
| EBITDA(a) | $-42,632 | $-39,949 | $-35,737 | $-26,855 | $-24,591 |